Immuron (IMRN) EBT (2016 - 2024)
Immuron (IMRN) posted quarterly EBT of $1660259165.7 billion for Q4 2024, up 80082653894883.1% year-over-year from N/an in Q1 2024, and up 80082653894883.1% quarter-over-quarter from -$2.1 million in Q4 2023.
Immuron (IMRN) EBT (2016 - 2024) Analysis & Trends
Immuron's EBT history runs 9 years deep, the most recent figure standing at $1660259165.7 billion for Q4 2024.
- In Q4 2024, EBT rose 80082653894883.1% year-over-year to $1660259165.7 billion; the TTM figure through Dec 2024 stood at $1660259165.7 billion (up 31304701745536.64% YoY), while the FY2025 annual figure was -$3.4 million, up 25.67% from the prior year.
- EBT for Q4 2024 stood at $1660259165.7 billion, up from -$2.1 million in the prior quarter.
- The five-year high for EBT was $1660259165.7 billion in Q4 2024, with the low at -$2.1 million in Q4 2023.
- The 5-year median for EBT is -$648054.1 (2020), against an average of $276709860.9 billion.
- The sharpest annual moves came in 2022 and 2024: EBT slumped 14819.74% in 2022, then jumped 80082653894883.1% in 2024.
- Immuron's EBT stood at -$57387.7 in 2020, then surged by 76.89% to -$13260.2 in 2021, then plunged by 14819.74% to -$2.0 million in 2022, then retreated by 4.79% to -$2.1 million in 2023, then surged by 80082653894883.1% to $1660259165.7 billion in 2024.
- Business Quant data shows IMRN's EBT at $1660259165.7 billion in Q4 2024, -$2.1 million in Q4 2023, and -$1.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,660,259,165.67 Bn |
| Dec 31, 2023 | -2.07 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -1.98 Mn |
| Dec 31, 2021 | -13,260.17 |
| Dec 31, 2020 | -57,387.72 |
| Dec 31, 2019 | -15,212.27 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | -1.45 Mn |
| Dec 31, 2016 | -2.60 Mn |
| Jun 30, 2016 | -3.28 Mn |